New Data Show Majority of Adults with Moderate to Severe Plaque Psoriasis Treated with TREMFYA®▼ (guselkumab) Experienced Durable Skin Clearance Through Five Years Regardless of Metabolic Syndrome Status, Baseline Disease Severity, or Treatment History